Pharmaceutical industry in India

Biopharmaceuticals Contract Manufacturing Market Size Worth $25.1 Billion By 2028: Grand View Research, Inc.

Retrieved on: 
Monday, January 25, 2021
Life sciences, Pharmaceutical industry, Health sciences, Biotechnology, Biopharmaceutical, Pharmacy, Pharmaceutical industry in India, Contract manufacturing organization

SAN FRANCISCO, Jan. 25, 2021 /PRNewswire/ -- The global biopharmaceuticals contract manufacturing market size is expected to reach USD 25.1 billion by 2028 registering a CAGR of 5.7% from 2021 to 2028, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, Jan. 25, 2021 /PRNewswire/ -- The global biopharmaceuticals contract manufacturing market size is expected to reach USD 25.1 billion by 2028 registering a CAGR of 5.7% from 2021 to 2028, according to a new report by Grand View Research, Inc.
  • Growing biopharmaceutical pipeline and lack of adequate manufacturing capabilities are two key factors that are driving partnership between large molecule manufacturers and Contract Manufacturing Organizations (CMOs).
  • Contract manufacturers are engaged in broadening their service portfolio to meet the company demands with respect to regulatory standards and new services.
  • The supply chain of biopharmaceuticals remained robust and was largely unaffected worldwide during the coronavirus outburst.

Biopharmaceuticals Contract Manufacturing Market Size Worth $25.1 Billion By 2028: Grand View Research, Inc.

Retrieved on: 
Monday, January 25, 2021
Life sciences, Pharmaceutical industry, Health sciences, Biotechnology, Biopharmaceutical, Pharmacy, Pharmaceutical industry in India, Contract manufacturing organization

SAN FRANCISCO, Jan. 25, 2021 /PRNewswire/ -- The global biopharmaceuticals contract manufacturing market size is expected to reach USD 25.1 billion by 2028 registering a CAGR of 5.7% from 2021 to 2028, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, Jan. 25, 2021 /PRNewswire/ -- The global biopharmaceuticals contract manufacturing market size is expected to reach USD 25.1 billion by 2028 registering a CAGR of 5.7% from 2021 to 2028, according to a new report by Grand View Research, Inc.
  • Growing biopharmaceutical pipeline and lack of adequate manufacturing capabilities are two key factors that are driving partnership between large molecule manufacturers and Contract Manufacturing Organizations (CMOs).
  • Contract manufacturers are engaged in broadening their service portfolio to meet the company demands with respect to regulatory standards and new services.
  • The supply chain of biopharmaceuticals remained robust and was largely unaffected worldwide during the coronavirus outburst.

2021 Career Connect Day – B.C.’s Largest Life Sciences Job Fair Attracts Top Employers

Retrieved on: 
Wednesday, January 20, 2021
Health, Other Health, Other Science, General Health, Research, Science, Biotechnology, Companies, Biotechnology companies, Stemcell Technologies, Zymeworks, AbCellera, Starfish, Amgen, Pharmaceutical industry in India, Health care

and BioTalent Canada , the Human Resources partner and facilitator for talent growth in Canadas bio-economy, are partnering once again to bring together the largest life sciences job fair in B.C., the virtual LifeSciences BC Career Connect Day event on January 22, 2021.

Key Points: 
  • and BioTalent Canada , the Human Resources partner and facilitator for talent growth in Canadas bio-economy, are partnering once again to bring together the largest life sciences job fair in B.C., the virtual LifeSciences BC Career Connect Day event on January 22, 2021.
  • Now in its second year, this highly successful networking event addresses that gap by helping life sciences companies connect with STEM grads, along with all those seeking new opportunities to either begin or enhance their careers in the life sciences sector.
  • Attendees will get the opportunity to connect with top life sciences companies like, Xenon Pharmaceuticals, Precision NanoSystems, STEMCELL Technologies, Amgen British Columbia, Zymeworks, AbCellera, StarFish Medical, UBC and many others.
  • The Career Connect Day provides an incredible opportunity to bring together compatible employers and employees in this specialized sector, said Ravi Kahlon, Minister of Jobs, Economic Recovery and Innovation.

Rockwell Medical Announces Dosing of First Patient in Pivotal Triferic® Phase 3 Trial by Partner, Wanbang Biopharmaceuticals, in China

Retrieved on: 
Wednesday, January 13, 2021
Life sciences, Health sciences, Health care, Healthcare in India, Pharmaceutical industry in India, Biopharmaceutical, Pharmaceutical industry in China, Avnu Alliance

Wanbang Biopharmaceuticals is a leading pharmaceutical company and an outstanding partner to bring our therapy to patients in China.

Key Points: 
  • Wanbang Biopharmaceuticals is a leading pharmaceutical company and an outstanding partner to bring our therapy to patients in China.
  • We value our partnership with Rockwell Medical, and our collaboration enhances Wanbang Biopharmaceuticals pipeline of innovative product candidates.
  • Rockwell Medical signed exclusive licensing and manufacturing supply agreements in 2016 with Wanbang Biopharmaceuticals for the rights to commercialize Triferic in China.
  • Triferic is a registered trademark of Rockwell Medical, Inc. Triferic AVNU is pending with the U.S. Patent and Trademark Office.

Contract Research Organizations (CRO) Market by Services, Therapeutic Area, End-user and Geography - Global Forecast to 2027

Retrieved on: 
Monday, January 11, 2021
Life sciences, Biotechnology, Articles, Health sciences, Pharmaceutical industry, Pharmaceuticals policy, Clinical research, Contract research organization, Biopharmaceutical, Bioprocess, Market, Pharmaceutical industry in India

The global contract research organizations market is expected to grow at a CAGR of 6.5% from 2020 to 2027 to reach $64.4 billion by 2027.

Key Points: 
  • The global contract research organizations market is expected to grow at a CAGR of 6.5% from 2020 to 2027 to reach $64.4 billion by 2027.
  • The growth in the contract research organizations market is mainly attributed to the rising demand for biopharmaceuticals, an increasing number of clinical trials, and growing government support for biopharmaceutical manufacturing.
  • Moreover, opportunities from emerging markets, increasing demand for biosimilars, and continuous advancements in bioprocessing techniques offer significant opportunities for players operating in the contract research organizations market.
  • North America commanded the largest share of the global contract research organizations market in 2019, followed by Asia-Pacific, Europe, Latin America, and the Middle East & Africa.

Nanovalent Presents New Data at Biotech Showcase 2021 Including Significant GMB Data

Retrieved on: 
Monday, January 11, 2021
Healthcare in India, Pharmaceutical industry in India, Health, Pharmaceutical industry in China

Bozeman, Montana--(Newsfile Corp. - January 11, 2021) - Nanovalent Pharmaceuticals has been selected to present at the 2021 Biotech Showcase, a premier investor conference held each year during the week of the JP Morgan Healthcare Investment Week.

Key Points: 
  • Bozeman, Montana--(Newsfile Corp. - January 11, 2021) - Nanovalent Pharmaceuticals has been selected to present at the 2021 Biotech Showcase, a premier investor conference held each year during the week of the JP Morgan Healthcare Investment Week.
  • This year, the conferences will be held digitally, and Nanovalent will have a pre-recorded presentation available beginning January 11, 2021.
  • The Biotech Showcase is designed to get presenting companies and funded technologies in front of potential investors and strategic partners.
  • Nanovalent issued US patent relating to its application of targeted polymerized nanoparticles in cancer.

Global Biotechnology Services Market Report 2020: Market to Grow at a CAGR of 5% from 2019 to 2020 Due to COVID-19 and Increase in R&D Activities - Forecast to 2030

Retrieved on: 
Friday, January 8, 2021
Life sciences, Health sciences, Health care, Pharmaceuticals policy, Science and technology in the People's Republic of China, Healthcare in India, Pharmaceutical industry in India, Novartis, Pfizer, Pharmaceutical industry in China, Novo Nordisk, Biotechnology

Biotechnology Services Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global biotechnology services market.

Key Points: 
  • Biotechnology Services Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global biotechnology services market.
  • Major players in the biotechnology services market are Novartis, Fisher BioService, Pfizer, Novo Nordisk, BioAlps, Precision for Medicine, Sartorius and Aldevron.
  • The global biotechnology services market is expected to increase from $142.92 billion in 2019 to $150.06 billion in 2020 at a compound annual growth rate (CAGR) of 5.0%.
  • Biotechnology services is the second-largest sector after biopharmaceuticals which is anticipated to emerge significantly due to increasing research and development activities.

Global Contract Research Organizations Market (2020 to 2027) - Increasing Demand for Biosimilars Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Friday, January 8, 2021
Health, Clinical trials, Research, Pharmaceutical, Science, Biotechnology, Life sciences, Biotechnology, Articles, Health sciences, Pharmaceutical industry, Pharmaceuticals policy, Clinical research, Contract research organization, Biopharmaceutical, Bioprocess, Market, Pharmaceutical industry in India

The global contract research organizations market is expected to grow at a CAGR of 6.5% from 2020 to 2027 to reach $64.4 billion by 2027.

Key Points: 
  • The global contract research organizations market is expected to grow at a CAGR of 6.5% from 2020 to 2027 to reach $64.4 billion by 2027.
  • The growth in the contract research organizations market is mainly attributed to the rising demand for biopharmaceuticals, an increasing number of clinical trials, and growing government support for biopharmaceutical manufacturing.
  • Moreover, opportunities from emerging markets, increasing demand for biosimilars, and continuous advancements in bioprocessing techniques offer significant opportunities for players operating in the contract research organizations market.
  • North America commanded the largest share of the global contract research organizations market in 2019, followed by Asia-Pacific, Europe, Latin America, and the Middle East & Africa.

The Pharmaceutical Industry in South Africa 2020 - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 31, 2020
Health, Pharmaceutical, Health care, Health sciences, Health, Pharmaceuticals policy, Pharmaceutical industry in China, Pharmacy in China, Science and technology in the People's Republic of China, Pharmaceutical industry in India, Pharmaceutical industry, Dishman Pharmaceuticals and Chemicals, Dr. Reddy's Laboratories

"The Pharmaceutical Industry in South Africa 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • "The Pharmaceutical Industry in South Africa 2020" report has been added to ResearchAndMarkets.com's offering.
  • The pharmaceutical sector is dominated by multinational pharmaceutical companies.
  • While almost 70% of the pharmaceutical products that are used are locally-produced, various active pharmaceutical ingredients and finished products are imported.
  • This report focuses on the manufacture of pharmaceuticals in South Africa and includes the wholesale and retail trade in pharmaceutical products.

CANbridge Pharmaceuticals Appoints General Manager of China

Retrieved on: 
Tuesday, December 22, 2020
Biotechnology, General Health, Pharmaceutical, Health, Companies, Life sciences, Industries, Novartis, Pharmaceutical industry in China, Bayer, Pharmaceutical industry in India

CANbridge Pharmaceuticals Inc., a company developing and commercializing innovative drugs to treat rare diseases and targeted cancers, announced that it has appointed Justin Lu to the position of General Manager of China, responsible for setting up and operating commercial operations in China.

Key Points: 
  • CANbridge Pharmaceuticals Inc., a company developing and commercializing innovative drugs to treat rare diseases and targeted cancers, announced that it has appointed Justin Lu to the position of General Manager of China, responsible for setting up and operating commercial operations in China.
  • Prior to that, he was Senior Regional Sales Manager at Bayer Healthcare, in Shanghai, China, where he worked in specialty healthcare and was responsible for Nexavar in Eastern China.
  • Earlier, he was the Senior Regional Sales Manager at Bayer Healthcare and Senior Regional Sales Manager at Beijing Novartis Pharma.
  • CANbridge Pharmaceuticals Inc. is a biopharmaceutical company accelerating development and commercialization of specialty healthcare products for orphan diseases and targeted cancers to address unmet medical needs.